Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding | |
Chromosome | 16 | Map location | 16p11.2 | dbXrefs | Entrez:930 MIM:107265 HGNC:HGNC:1633 Ensembl:ENSG00000177455 AllianceGenome:HGNC:1633 | |
Description | CD19 molecule |
GTO ID | GTC3009 |
Trial ID | NCT05349266 |
Disease | Non-Hodgkin's Lymphoma |
Altered gene | CD19 |
Therapeutic/Target gene | Target gene |
Therapy | CAR-T cell |
Treatment | ThisCAR-T19A |
Generation | 2nd |
Phase | Phase1 |
Recruitment status | Recruiting |
Title | Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B-NHL After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy |
Year | 2022 |
Country | China |
Company sponsor | Zhejiang University |
Other ID(s) | FT400-003 |
Cohort1: dose level 1 | |||||||||||
|
|||||||||||
Cohort2: dose level 2 | |||||||||||
|
|||||||||||
Cohort3: dose level 3 | |||||||||||
|